Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

• Status: Recruiting
• Trial end date: 2022-09-08
• Target enrollment: 0
• Participant gender: All

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

Criteria

Inclusion Criteria:

• Patients with primary hypercholesterolemia

Exclusion Criteria:

• The subject not meet the specified LDL-C level